Retargeting of viruses to generate oncolytic agents

Area of Science:

• Oncolytic virotherapy
• Molecular biology
• Cancer research

Background:

• Oncolytic virus therapy selectively targets and eliminates tumor cells.
• Viral tropism modification is crucial for efficient tumor cell entry and replication.
• Targeting strategies enhance oncolytic virus specificity for cancer cells.

Purpose of the Study:

• To review current transductional targeting strategies for oncolytic viruses.
• To discuss methods for redirecting viruses to tumor cell surface receptors.
• To highlight engineered viruses with self-targeting capabilities.

Main Methods:

• Review of scientific literature on viral targeting strategies.
• Categorization of targeting approaches into three main types.
• Analysis of viral surface protein modifications and bispecific adapters.
• Discussion of self-targeting viruses engineered for genomic expression.

Main Results:

• Three primary transductional targeting strategies are identified: modifying viral surface proteins, incorporating scaffolds for targeting moieties, and using bispecific adapters.
• Each strategy offers distinct advantages and limitations for oncolytic virus application.
• Engineered viruses expressing bispecific adapter proteins demonstrate potential for sustained, multiround infections and self-targeting.

Conclusions:

• Transductional targeting significantly enhances the specificity and efficacy of oncolytic virus therapy.
• Novel strategies, including self-targeting viruses, offer promising avenues for improved cancer treatment.
• Further research into these targeting mechanisms is essential for advancing oncolytic virotherapy.